The New HFrontier: ATTR Amyloidosis
Watch the on-demand recording of this webinar that was presented by the Canadian Heart Failure Society entitled The New HFrontier: Successfully Addressing Clinical Challenges in Worsening HF and ATTR Amyloidosis. Our guest speakers, Dr. Nowel Fine and Dr. Lisa Mielniczuk will discuss novel data, treatment, and clinical recommendations around worsening heart failure and ATTR amyloidosis.
Scientific Planning Committee
Anique Ducharme, MD, FRCPC, FCCS, FACC
Justin Ezekowitz, MBBCh, MSc
Nowell Fine, MD, SM, FRCPC, FACC, FCCS, FASE, FHFSA
Lisa Mielniczuk, MD, FRCPC
The CHFS has received an educational grant from Bayer Inc., Alnylam and Pfizer for this initiative.